Cellectis SA (CLLS)
4.82
+0.14
(+2.99%)
USD |
NASDAQ |
Dec 15, 16:00
4.50
-0.32
(-6.64%)
After-Hours: 19:05
Cellectis Research and Development Expense (TTM): 70.72M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EDAP TMS SA | 9.515M |
| DBV Technologies SA | 95.77M |
| Genfit SA | 56.45M |
| Ascendis Pharma A/S | 326.69M |
| Akari Therapeutics Plc | 2.971M |